Olmesartan Medoxomil in Hypertension and Renal Impairment

This study has been completed.
Information provided by Daiichi Sankyo Inc.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Essential Hypertension
			Renal Impairment
2		Additional conditions recognized in this trial
			Hypertension
3		More general conditions related to this trial
			Cardiovascular Diseases
			Vascular Diseases
4		Interventions listed in this trial
			Olmesartan medoxomil
			Losartan
			Furosemide
5		More general drug interventions related to this trial
			Angiotensin II Type 1 Receptor Blockers
			Anti-Arrhythmia Agents
			Antihypertensive Agents
			Cardiovascular Agents
			Diuretics
			Membrane Transport Modulators
			Molecular Mechanisms of Pharmacological Action
			Natriuretic Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Sodium Potassium Chloride Symporter Inhibitors
			Therapeutic Uses
6		Sponsors listed in this trial
			Sankyo Pharma Gmbh